$2.04
0.063.03%
At close: -
$2.04
00.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Mersana Therapeutics (MRSN) Forecast
NewsEarningsMersana Therapeutics (MRSN) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestMersana Therapeutics (NASDAQ:MRSN) Stock Quotes, Forecast and News Summary
Mersana Therapeutics Stock (NASDAQ: MRSN) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Mersana Therapeutics (MRSN) stock?
You can purchase shares of Mersana Therapeutics (NASDAQ:MRSN) through any online brokerage.
Who are Mersana Therapeutics (MRSN) competitors?
Other companies in Mersana Therapeutics’s space includes: Precigen (NASDAQ:PGEN), Zentalis Pharma (NASDAQ:ZNTL), Fate Therapeutics (NASDAQ:FATE), Anika Therapeutics (NASDAQ:ANIK) and Eledon Pharma (NASDAQ:ELDN).
What is the forecast, or price target, for Mersana Therapeutics (MRSN) stock?
Mersana Therapeutics has a consensus price target of $6.38.
What is the current price for Mersana Therapeutics (MRSN)?
The stock price for Mersana Therapeutics (NASDAQ: MRSN) is $2.04 last updated November 22, 2024 at 4:00 PM EST.
Does Mersana Therapeutics (MRSN) pay a dividend?
There are no upcoming dividends for Mersana Therapeutics.
When is Mersana Therapeutics (NASDAQ:MRSN) reporting earnings?
Mersana Therapeutics’s Q3 earnings are confirmed for Wednesday, November 13, 2024.
Is Mersana Therapeutics (MRSN) going to split?
There is no upcoming split for Mersana Therapeutics.
What sector and industry does Mersana Therapeutics (MRSN) operate in?
Mersana Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.